Global Restless Legs Syndrome Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 121 pages | ID: GA9A874596EGEN
GlobalInfoResearch

Abstracts

Restless legs syndrome (RLS) is a neurological disease. RLS is also called as Willis-Ekbom disease. Patients suffering from RLS disease have an irresistible desire to move their feet. The continual movement of the legs leads to pain in the limbs, which leads to the unusual sleep pattern of patients.

SCOPE OF THE REPORT:

The global Restless Legs Syndrome market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Restless Legs Syndrome.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Restless Legs Syndrome market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Restless Legs Syndrome market by product type and applications/end industries.
Market Segment by Companies, this report covers

• GlaxoSmithKline plc.
• Ligand Pharmaceuticals Incorporated
• axxonis Pharma AG
• Kyowa Hakko Kirin Co.
• Jazz Pharmaceuticals, Inc.
• Omeros Corporation
• Manhattan Pharmaceuticals
• Boehringer Ingelheim GmbH
• UCB SA

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Pharmacological Therapy
• Non-Pharmacological Therapy

Market Segment by Applications, can be divided into

• < 35 Years Old
• 35-50 Years Old
• > 50 Years Old

Contents

1 RESTLESS LEGS SYNDROME MARKET OVERVIEW

1.1 Product Overview and Scope of Restless Legs Syndrome
1.2 Classification of Restless Legs Syndrome by Types
  1.2.1 Global Restless Legs Syndrome Revenue Comparison by Types (2017-2023)
  1.2.2 Global Restless Legs Syndrome Revenue Market Share by Types in 2017
  1.2.3 Pharmacological Therapy
  1.2.4 Non-Pharmacological Therapy
1.3 Global Restless Legs Syndrome Market by Application
  1.3.1 Global Restless Legs Syndrome Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 < 35 Years Old
  1.3.3 35-50 Years Old
  1.3.4 > 50 Years Old
1.4 Global Restless Legs Syndrome Market by Regions
  1.4.1 Global Restless Legs Syndrome Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Restless Legs Syndrome Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Restless Legs Syndrome Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Restless Legs Syndrome Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Restless Legs Syndrome Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Restless Legs Syndrome Status and Prospect (2013-2023)
1.5 Global Market Size of Restless Legs Syndrome (2013-2023)

2 MANUFACTURERS PROFILES

2.1 GlaxoSmithKline plc.
  2.1.1 Business Overview
  2.1.2 Restless Legs Syndrome Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 GlaxoSmithKline plc. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.2 Ligand Pharmaceuticals Incorporated
  2.2.1 Business Overview
  2.2.2 Restless Legs Syndrome Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.3 axxonis Pharma AG
  2.3.1 Business Overview
  2.3.2 Restless Legs Syndrome Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 axxonis Pharma AG Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.4 Kyowa Hakko Kirin Co.
  2.4.1 Business Overview
  2.4.2 Restless Legs Syndrome Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Kyowa Hakko Kirin Co. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.5 Jazz Pharmaceuticals, Inc.
  2.5.1 Business Overview
  2.5.2 Restless Legs Syndrome Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.6 Omeros Corporation
  2.6.1 Business Overview
  2.6.2 Restless Legs Syndrome Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Omeros Corporation Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.7 Manhattan Pharmaceuticals
  2.7.1 Business Overview
  2.7.2 Restless Legs Syndrome Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Manhattan Pharmaceuticals Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.8 Boehringer Ingelheim GmbH
  2.8.1 Business Overview
  2.8.2 Restless Legs Syndrome Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
2.9 UCB SA
  2.9.1 Business Overview
  2.9.2 Restless Legs Syndrome Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 UCB SA Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL RESTLESS LEGS SYNDROME MARKET COMPETITION, BY PLAYERS

3.1 Global Restless Legs Syndrome Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Restless Legs Syndrome Players Market Share
  3.2.2 Top 10 Restless Legs Syndrome Players Market Share
3.3 Market Competition Trend

4 GLOBAL RESTLESS LEGS SYNDROME MARKET SIZE BY REGIONS

4.1 Global Restless Legs Syndrome Revenue and Market Share by Regions
4.2 North America Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
4.3 Europe Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
4.5 South America Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Restless Legs Syndrome Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA RESTLESS LEGS SYNDROME REVENUE BY COUNTRIES

5.1 North America Restless Legs Syndrome Revenue by Countries (2013-2018)
5.2 USA Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
5.3 Canada Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
5.4 Mexico Restless Legs Syndrome Revenue and Growth Rate (2013-2018)

6 EUROPE RESTLESS LEGS SYNDROME REVENUE BY COUNTRIES

6.1 Europe Restless Legs Syndrome Revenue by Countries (2013-2018)
6.2 Germany Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
6.3 UK Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
6.4 France Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
6.5 Russia Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
6.6 Italy Restless Legs Syndrome Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC RESTLESS LEGS SYNDROME REVENUE BY COUNTRIES

7.1 Asia-Pacific Restless Legs Syndrome Revenue by Countries (2013-2018)
7.2 China Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
7.3 Japan Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
7.4 Korea Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
7.5 India Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Restless Legs Syndrome Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA RESTLESS LEGS SYNDROME REVENUE BY COUNTRIES

8.1 South America Restless Legs Syndrome Revenue by Countries (2013-2018)
8.2 Brazil Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
8.3 Argentina Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
8.4 Colombia Restless Legs Syndrome Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE RESTLESS LEGS SYNDROME BY COUNTRIES

9.1 Middle East and Africa Restless Legs Syndrome Revenue by Countries (2013-2018)
9.2 Saudi Arabia Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
9.3 UAE Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
9.4 Egypt Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
9.5 Nigeria Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
9.6 South Africa Restless Legs Syndrome Revenue and Growth Rate (2013-2018)

10 GLOBAL RESTLESS LEGS SYNDROME MARKET SEGMENT BY TYPE

10.1 Global Restless Legs Syndrome Revenue and Market Share by Type (2013-2018)
10.2 Global Restless Legs Syndrome Market Forecast by Type (2018-2023)
10.3 Pharmacological Therapy Revenue Growth Rate (2013-2023)
10.4 Non-Pharmacological Therapy Revenue Growth Rate (2013-2023)

11 GLOBAL RESTLESS LEGS SYNDROME MARKET SEGMENT BY APPLICATION

11.1 Global Restless Legs Syndrome Revenue Market Share by Application (2013-2018)
11.2 Restless Legs Syndrome Market Forecast by Application (2018-2023)
11.3 < 35 Years Old Revenue Growth (2013-2018)
11.4 35-50 Years Old Revenue Growth (2013-2018)
11.5 > 50 Years Old Revenue Growth (2013-2018)

12 GLOBAL RESTLESS LEGS SYNDROME MARKET SIZE FORECAST (2018-2023)

12.1 Global Restless Legs Syndrome Market Size Forecast (2018-2023)
12.2 Global Restless Legs Syndrome Market Forecast by Regions (2018-2023)
12.3 North America Restless Legs Syndrome Revenue Market Forecast (2018-2023)
12.4 Europe Restless Legs Syndrome Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Restless Legs Syndrome Revenue Market Forecast (2018-2023)
12.6 South America Restless Legs Syndrome Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Restless Legs Syndrome Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Restless Legs Syndrome Picture
Table Product Specifications of Restless Legs Syndrome
Table Global Restless Legs Syndrome and Revenue (Million USD) Market Split by Product Type
Figure Global Restless Legs Syndrome Revenue Market Share by Types in 2017
Figure Pharmacological Therapy Picture
Figure Non-Pharmacological Therapy Picture
Table Global Restless Legs Syndrome Revenue (Million USD) by Application (2013-2023)
Figure Restless Legs Syndrome Revenue Market Share by Applications in 2017
Figure < 35 Years Old Picture
Figure 35-50 Years Old Picture
Figure > 50 Years Old Picture
Table Global Market Restless Legs Syndrome Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Restless Legs Syndrome Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Restless Legs Syndrome Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Restless Legs Syndrome Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Restless Legs Syndrome Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Restless Legs Syndrome Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Restless Legs Syndrome Revenue (Million USD) and Growth Rate (2013-2023)
Table GlaxoSmithKline plc. Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc. Restless Legs Syndrome Type and Applications
Table GlaxoSmithKline plc. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Ligand Pharmaceuticals Incorporated Basic Information, Manufacturing Base and Competitors
Table Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Type and Applications
Table Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table axxonis Pharma AG Basic Information, Manufacturing Base and Competitors
Table axxonis Pharma AG Restless Legs Syndrome Type and Applications
Table axxonis Pharma AG Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Kyowa Hakko Kirin Co. Basic Information, Manufacturing Base and Competitors
Table Kyowa Hakko Kirin Co. Restless Legs Syndrome Type and Applications
Table Kyowa Hakko Kirin Co. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Jazz Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Type and Applications
Table Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Omeros Corporation Basic Information, Manufacturing Base and Competitors
Table Omeros Corporation Restless Legs Syndrome Type and Applications
Table Omeros Corporation Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Manhattan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Manhattan Pharmaceuticals Restless Legs Syndrome Type and Applications
Table Manhattan Pharmaceuticals Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim GmbH Restless Legs Syndrome Type and Applications
Table Boehringer Ingelheim GmbH Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table UCB SA Basic Information, Manufacturing Base and Competitors
Table UCB SA Restless Legs Syndrome Type and Applications
Table UCB SA Restless Legs Syndrome Revenue, Gross Margin and Market Share (2016-2017)
Table Global Restless Legs Syndrome Revenue (Million USD) by Players (2013-2018)
Table Global Restless Legs Syndrome Revenue Share by Players (2013-2018)
Figure Global Restless Legs Syndrome Revenue Share by Players in 2016
Figure Global Restless Legs Syndrome Revenue Share by Players in 2017
Figure Global Top 5 Players Restless Legs Syndrome Revenue Market Share in 2017
Figure Global Top 10 Players Restless Legs Syndrome Revenue Market Share in 2017
Figure Global Restless Legs Syndrome Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Restless Legs Syndrome Revenue (Million USD) by Regions (2013-2018)
Table Global Restless Legs Syndrome Revenue Market Share by Regions (2013-2018)
Figure Global Restless Legs Syndrome Revenue Market Share by Regions (2013-2018)
Figure Global Restless Legs Syndrome Revenue Market Share by Regions in 2017
Figure North America Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Europe Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure South America Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Table North America Restless Legs Syndrome Revenue by Countries (2013-2018)
Table North America Restless Legs Syndrome Revenue Market Share by Countries (2013-2018)
Figure North America Restless Legs Syndrome Revenue Market Share by Countries (2013-2018)
Figure North America Restless Legs Syndrome Revenue Market Share by Countries in 2017
Figure USA Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Canada Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Mexico Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Table Europe Restless Legs Syndrome Revenue (Million USD) by Countries (2013-2018)
Figure Europe Restless Legs Syndrome Revenue Market Share by Countries (2013-2018)
Figure Europe Restless Legs Syndrome Revenue Market Share by Countries in 2017
Figure Germany Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure UK Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure France Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Russia Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Italy Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Restless Legs Syndrome Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Restless Legs Syndrome Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Restless Legs Syndrome Revenue Market Share by Countries in 2017
Figure China Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Japan Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Korea Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure India Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Table South America Restless Legs Syndrome Revenue by Countries (2013-2018)
Table South America Restless Legs Syndrome Revenue Market Share by Countries (2013-2018)
Figure South America Restless Legs Syndrome Revenue Market Share by Countries (2013-2018)
Figure South America Restless Legs Syndrome Revenue Market Share by Countries in 2017
Figure Brazil Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Argentina Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Colombia Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Restless Legs Syndrome Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Restless Legs Syndrome Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Restless Legs Syndrome Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Restless Legs Syndrome Revenue Market Share by Countries in 2017
Figure Saudi Arabia Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure UAE Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Egypt Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure Nigeria Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Figure South Africa Restless Legs Syndrome Revenue and Growth Rate (2013-2018)
Table Global Restless Legs Syndrome Revenue (Million USD) by Type (2013-2018)
Table Global Restless Legs Syndrome Revenue Share by Type (2013-2018)
Figure Global Restless Legs Syndrome Revenue Share by Type (2013-2018)
Figure Global Restless Legs Syndrome Revenue Share by Type in 2017
Table Global Restless Legs Syndrome Revenue Forecast by Type (2018-2023)
Figure Global Restless Legs Syndrome Market Share Forecast by Type (2018-2023)
Figure Global Pharmacological Therapy Revenue Growth Rate (2013-2018)
Figure Global Non-Pharmacological Therapy Revenue Growth Rate (2013-2018)
Table Global Restless Legs Syndrome Revenue by Application (2013-2018)
Table Global Restless Legs Syndrome Revenue Share by Application (2013-2018)
Figure Global Restless Legs Syndrome Revenue Share by Application (2013-2018)
Figure Global Restless Legs Syndrome Revenue Share by Application in 2017
Table Global Restless Legs Syndrome Revenue Forecast by Application (2018-2023)
Figure Global Restless Legs Syndrome Market Share Forecast by Application (2018-2023)
Figure Global < 35 Years Old Revenue Growth Rate (2013-2018)
Figure Global 35-50 Years Old Revenue Growth Rate (2013-2018)
Figure Global > 50 Years Old Revenue Growth Rate (2013-2018)
Figure Global Restless Legs Syndrome Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Restless Legs Syndrome Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Restless Legs Syndrome Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Restless Legs Syndrome Revenue Market Forecast (2018-2023)
Figure Europe Restless Legs Syndrome Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Restless Legs Syndrome Revenue Market Forecast (2018-2023)
Figure South America Restless Legs Syndrome Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Restless Legs Syndrome Revenue Market Forecast (2018-2023)